Indicators

Markets:

News

Latest News about NVS

Recent news which mentions NVS

...

11 12 13 14 15 16 17 18 19

...

Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says

April 13, 2023

Novartis Earnings Conference Call Is Coming Up, Here's What You Need To Know

April 13, 2023

Alzheimer's Disease Largely Remains A Mystery, With A Lack Of Highly Effective Treatments — Could Regulatory T-Cells (Tregs) Be The Answer?

April 13, 2023

Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move

April 10, 2023

Cryoport Supports Clinical Trials And Commercial Therapies Across The High-Growth BioTech Industry: Is Its Current Stock Price An Opportunity?

April 10, 2023

6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'

April 07, 2023

7 Very Undervalued Penny Stocks to Buy in April 2023

April 06, 2023

What Bear Market? These 2 Winning Stocks Are Still Worth Buying.

March 30, 2023

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session

March 27, 2023

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories

March 27, 2023

FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy

March 27, 2023

Why Novartis Shares Are Trading Higher Premarket Today

March 27, 2023

First Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trial

March 27, 2023

First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session

March 27, 2023

How Is The Market Feeling About Novartis?

March 21, 2023

2 Biotech Stocks That Could Make You Richer

March 21, 2023

Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo

March 20, 2023

Novartis Reveals Long-Term Data Of Atrophy Gene Therapy Exhibiting Sustained Durability Of Up To 7.5 Years

March 20, 2023

FDA Approves Novartis' Tafinlar + Mekinist For Pediatric Brain Cancer With Certain Mutations

March 17, 2023

Elon Musk Frets As Microsoft Axes AI Ethics Team, Richard Branson's Virgin Orbit Stops Ops, Credit Suisse To Borrow Up To $54B: Today's Top Stories

March 16, 2023

Novartis' Prostate Cancer Therapy Hit By Supply Crunch, Seeks To Ramp Up Production To Ease Supply Issues

March 16, 2023

3 High Dividend Stocks With Attractive Total Return Potential

March 10, 2023

Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?

March 07, 2023

4 AI Stocks That Are Revolutionizing Healthcare

March 06, 2023

This Company Is Focused on Treg-Enhancing Therapies - Could This Be Medicine's Next Frontier?

March 03, 2023

Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion

February 26, 2023

Novartis Takes Down $80M NASH Pact With Pliant Therapeutics

February 24, 2023

Better Buy: Beam Therapeutics or Intellia Therapeutics?

February 22, 2023

This chart gives one reason European stocks may continue to outperform U.S. equities

February 17, 2023

Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path

February 14, 2023

...

11 12 13 14 15 16 17 18 19

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.